Two phase 3 study results of children and adults with mild-to-moderate atopic dermatitis treated with Crisaborole Topical Ointment, 2%, a novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase 4 inhibitor

Authors

Andrea Zaenglein

Publication/Presentation Date

5-2016

Volume

196

Issue

1

Published In/Presented At

https://doi.org/10.4049/jimmunol.196.Supp.191.26

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine Faculty

Document Type

Article